pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,130
stories
19d
STAT+: Senators highlight the power Chris Klomp wields at confirmation hearings
stat
20d
Deep dive: Psychedelics back on FDA’s doorstep
biospace
20d
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
stat
20d
STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
stat
20d
Skyhawk racks up more support for Huntington’s drug
biopharma dive
20d
Sling catches $123M series C for thyroid eye disease pill
biospace
20d
U.S. reaches highest number of measles deaths in decades
stat
20d
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
biospace
20d
STAT+: House Democrats may use oversight powers to plan for health care overhaul
stat
20d
5 biotechs braving the commercial waters with product launches
biospace
20d
FDA clears first generic radioligand drug; Sionna turns to layoffs
biopharma dive
20d
A fourth measles death is reported in Pennsylvania
stat
20d
FDA approves first radioligand generic, setting up rivalry with Novartis
endpoints
21d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
21d
STAT+: FDA takes applications for new program to shorten drug approval times
stat
21d
Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting
biospace
21d
Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near market
biospace
21d
FDA Launches Expedited IND Pilot, Begins Accepting Applications
fda press
21d
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
21d
Despite 3 patient deaths, Cullinan-Taiho plan FDA filing for lung cancer pill on survival benefit
biospace
21d
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
biospace
21d
Vera eyes full approval for Trutakna in IgAN following positive readout
endpoints
21d
STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial
stat
21d
FDA should require credentials for psychedelic providers, experts say
endpoints
21d
After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer
fiercebiotech
21d
Judge blocks Trump administration plans to limit visa length for grad students, postdocs
stat
21d
Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
biopharma dive
21d
A&P Creations LLC Issues Nationwide Recall of biQ-FEL Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
A&P Creations LLC Issues Nationwide Recall of X10 Natural Enhancement Supplement Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
AAM sounds alarm on ‘unsustainable, race to the bottom’ for generics and biosimilars
biospace
← prev
page 7 of 38
next →
